Stephen Abbott

Stephen Abbott is a Principal Associate Scientist at Alnylam Pharmaceuticals since August 2019, with prior roles including Senior Associate Scientist at ImmunoGen, Inc. and bluebird bio. Stephen has extensive experience in study proposal development, in-vivo tolerability, pharmacokinetics, and pharmacodynamics, leading pharmacology project teams, and overseeing in-life experiments. Stephen's previous positions also include Research Associate II and Laboratory Technologist at Alexion Pharmaceuticals, where responsibilities encompassed coordinating outsourced studies, developing disease models, and executing in-vivo studies. Early career roles included various technician positions across organizations such as the Alaska Raptor Center and UCLA Health System, coupled with a Bachelor of Science in Biology from the University of Massachusetts Amherst.